Cargando…
Apremilast ameliorates ox-LDL-induced endothelial dysfunction mediated by KLF6
Apremilast is a phosphodiesterase 4 (PDE4) inhibitor used in the treatment of psoriasis and several other inflammatory diseases. Interest has been expressed in seeking out therapies that address both psoriasis and atherosclerosis. In the present study, we explored the effects of apremilast in human...
Autores principales: | Wang, Hao, Yang, Guang, Zhang, Qian, Liang, Xiao, Liu, Yang, Gao, Meng, Guo, Yutao, Chen, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732304/ https://www.ncbi.nlm.nih.gov/pubmed/33052879 http://dx.doi.org/10.18632/aging.103665 |
Ejemplares similares
-
Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2
por: Li, Wenfeng, et al.
Publicado: (2021) -
Effect of Selenium-Enriched Garlic Oil against Cytotoxicity Induced by OX-LDL in Endothelial Cells
por: Yang, Cheng, et al.
Publicado: (2014) -
Ox-LDL Induces Dysfunction of Endothelial Progenitor Cells via Activation of NF-κB
por: Ji, Kang-ting, et al.
Publicado: (2015) -
IRF2BP2 prevents ox-LDL-induced inflammation and EMT in endothelial cells via regulation of KLF2
por: Jiang, Yongri, et al.
Publicado: (2021) -
Pinoresinol Diglucoside Alleviates oxLDL-Induced Dysfunction in Human Umbilical Vein Endothelial Cells
por: Yao, Jinpeng, et al.
Publicado: (2016)